Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PARICALCITOL, with a corresponding US DMF Number 21880.
Remarkably, this DMF maintains an Active status since its submission on August 14, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 08, 2012, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II